Document Detail


Envelope fusion protein binding studies in an inducible model of retrovirus receptor expression and in CD34(+) cells emphasize limited transduction at low receptor levels.
MedLine Citation:
PMID:  11320405     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Successful gene therapy for the treatment of heritable or acquired diseases typically requires high efficiency gene transfer and sustained transgene expression. Indirect evidence on the basis of RNA analysis and in vivo competitive repopulation experiments in animal models suggests a correlation between transduction efficiency and the abundance of retrovirus receptors on the hematopoietic target cell. However, transduction by oncoretroviral vectors is also subject to other factors such as target cell cycle status and the composition of the virus-containing medium, making it difficult to determine the level of receptor expression required for efficient transduction. In the present study we investigated the impact of receptor expression level on transduction by a vector with a gibbon ape leukemia virus (GALV) envelope protein in a tetracycline-inducible tissue culture model that allowed for the cell cycle-independent, regulated expression of the GALV receptor (Pit1) in otherwise non-susceptible NIH 3T3 cells. Up-regulation of receptor RNA expression by 4.5-fold resulted in a mean 150-fold increase in transduction efficiency. We then analyzed cell surface expression of the Pit1 receptor using a fusion protein consisting of GALV SU portion of the viral envelope protein linked to the human IgG Fc. These experiments showed that tetracycline-regulated receptor induction resulted in a dose-dependent increase in binding of fusion protein. At maximum induction fusion protein binding increased up to five-fold which paralleled the increase in RNA expression, and correlated with the improved transduction efficiency. Finally, studies of pseudotype-specific fusion protein binding to human CD34-enriched cells revealed increased expression of retrovirus receptors after cytokine stimulation, although overall receptor expression in CD34(+)cells remained lower than in fibroblast cell lines efficiently transduced by amphotropic and GALV vectors.
Authors:
P Kurre; J Morris; A D Miller; H P Kiem
Related Documents :
23543845 - Sugar is an endogenous cue for juvenile-to-adult phase transition in plants.
19152075 - A high-level expression vector containing selectable marker for continuous production o...
7854045 - Enhancer trapping by a human mid-sized neurofilament transgene reveals unexpected patte...
7868895 - Regulatory regions 3' of the immunoglobulin heavy chain intronic enhancer differentiall...
22787275 - Collagen/β1 integrin signaling up-regulates the abcc1/mrp-1 transporter in an erk/mapk-...
18067885 - Spatial specificity of mesodermal even-skipped expression relies on multiple repressor ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Gene therapy     Volume:  8     ISSN:  0969-7128     ISO Abbreviation:  Gene Ther.     Publication Date:  2001 Apr 
Date Detail:
Created Date:  2001-04-26     Completed Date:  2001-06-07     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  9421525     Medline TA:  Gene Ther     Country:  England    
Other Details:
Languages:  eng     Pagination:  593-9     Citation Subset:  IM    
Affiliation:
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antigens, CD34 / analysis*,  immunology
Cell Culture Techniques
Cell Line
Cytokines / immunology
Genetic Vectors
Hematopoietic Stem Cells / immunology,  metabolism
Humans
Leukemia Virus, Gibbon Ape / genetics
Receptors, Virus / genetics,  metabolism*
Transduction, Genetic*
Viral Envelope Proteins / genetics
Grant Support
ID/Acronym/Agency:
DK47754/DK/NIDDK NIH HHS; HL36444/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Antigens, CD34; 0/Cytokines; 0/Receptors, Virus; 0/Viral Envelope Proteins; 0/leukemia virus receptor, gibbon ape

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Single chain Fv: a ligand in receptor-mediated gene delivery.
Next Document:  Efficient in vitro and in vivo gene regulation of a retrovirally delivered pro-apoptotic factor unde...